About Us

R&D

Micro Labs has a long term commitment to developing Bio – equivalent Generics with the help of world class research and high quality standards. Our research and development team consists of over 200 scientists and developers who are highly qualified and experienced in formulation and analytical development. Our focus remains on continuing to develop new formulations in various dosage forms including Solid dosage, liquid dosage, Sterile preparations, injectables, Creams, ointments etc.,.

 

The highlights of the R&D centres at Micro Labs include:
  •  

    Development of Generics

  •  

    Strict Compliance IPR / Non-infringing route

  •  

    Infrastructure includes facility for scale-up & validation

  •  

    Capability includes handling complex chemistries

  •  

    Regulatory complaint development & scale-up

  •  

    File EU-DMF / E-COS / US-DMF

  •  

    8 Molecules under development

The dosage forms and technologies developed by our R&D include:
  •  

    Immediate Release Solid Dosage Form (IR)

  •  

    Sustained Release tablet Technology (DR)

  •  

    Effervescent Technology

  •  

    Enteric Coated Technology

  •  

    Direct Compression Technology

  •  

    Oro dispersible tablet form

  •  

    Chewable tablet form

  •  

    Hot melt extrusion technology

  •  

    Tablet in capsule technology

Once a pharmaceutical product is developed, it undergoes the following:
  •  

    Conceiving and identifying product profile

  •  

    Pre formulation studies

  •  

    Lab formula development and development for stability & validation

  •  

    Scale up for process optimization /validation

  •  

    Analytical method development

  •  

    Pilot scale mfg in cGMP facility (Clinical supplies)

  •  

    Stability studies as per ICH guidelines

  •  

    Dossier preparation for submission/Technical assistance for contract manufacturing

  •  

    Data management (for transfer to customer/ regulatory Affairs)